Biogen Inc
NASDAQ:BIIB
Biogen Inc
Revenue
Biogen Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biogen Inc
NASDAQ:BIIB
|
Revenue
$9.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
2%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Biogen Inc
Revenue Breakdown
Breakdown by Geography
Biogen Inc
Breakdown by Segments
Biogen Inc
Total Revenue:
9.8B
USD
|
Product Revenue, Net:
7.2B
USD
|
Subtotal: Multiple Sclerosis:
4.7B
USD
|
Tysabri:
1.9B
USD
|
Subtotal: Rare Disease:
1.8B
USD
|
Spinraza:
1.7B
USD
|
Revenue From Anti-Cd20 Therapeutic Programs:
1.7B
USD
|
Total Fumarate:
1.6B
USD
|
Royalty Revenue On Sales Of Ocrevus:
1.3B
USD
|
Total Interferon:
1.1B
USD
|
Tecfidera:
1B
USD
|
Contract Manufacturing, Royalty And Other Rev...:
899.3m
USD
|
Contract Manufacturing Revenue:
848.2m
USD
|
Avonex:
811m
USD
|
Subtotal: Biosimilars:
770m
USD
|
Vumerity:
576.3m
USD
|
Benepali:
438.8m
USD
|
Plegridy:
294.7m
USD
|
Imraldi:
222.1m
USD
|
Fampyra:
90.5m
USD
|
Flixabi:
77.4m
USD
|
Completed Technology For Skyclarys (United St...:
55.9m
USD
|
Royalty And Other Revenue:
51.1m
USD
|
Byooviz:
31.7m
USD
|
Other:
11.8m
USD
|
Qalsody:
5.9m
USD
|
See Also
What is Biogen Inc's Revenue?
Revenue
9.7B
USD
Based on the financial report for Mar 31, 2024, Biogen Inc's Revenue amounts to 9.7B USD.
What is Biogen Inc's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Biogen Inc have been -8% over the past three years , -7% over the past five years , and 2% over the past ten years .